Antibody Drug Conjugate
Antibody Drug Conjugate (ADCs) are monoclonal antibodies attached to biologically active drugs by chemical linkers. These cytotoxic killers are a new frontier in immunotherapy offering tissue targeting capabilities for superior immunological response. Explore the 3D structure of an Antibody Drug Conjugate to learn more about how it combats cancer.
Monoclonal IgG4 Antibody bound to PD1
This is a 3D print of a humanized monoclonal IgG4 antibody used in multiple types of cancer treatments. Models available in multiple materials and sizes.
Protein Description This cytotoxic drug utilizes Molecular Templates an innovative Engineered Toxic Bodies (ETBs) drug delivery platform to trigger cell death. MT-3724 is being developed for the treatment of non-Hodgkin’s Lymphoma and harnesses the immunotherapy power of antibody receptor-specific targeting combined, a bacterial process for cell invasion that infects cancer cells with ribosomal inhibitors that […]